ArticleResearch and practice in thrombosis and haemostasis2026
Venous thromboembolism following surgery for pancreatic neuroendocrine neoplasms.
Article in Research and practice in thrombosis and haemostasis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Commentary: "Venous thromboembolism following surgery for pancreatic neuroendocrine neoplasms".Research and practice in thrombosis and haemostasis · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pancreatic neuroendocrine neoplasms (pNENs) are rare and clinically heterogeneous tumors with a growing incidence. Given the thrombotic risk associated with malignancy and major surgery, understanding the postoperative venous thromboembolism (VTE) in this population is essential for guiding prophylactic strategies. Objectives: The primary objectives were to determine the risk of postoperative VTE after pancreatectomy in patients with pNEN versus other histologies and to identify VTE risk factors in patients with pNEN. Methods: The Pancreatectomy-Targeted American College of Surgeons National Surgical Quality Improvement Program from 2014 to 2022 was used to compare 30-day postoperative VTE frequency following pancreatectomy for pNEN versus other pancreatic histologies. Multivariable logistic regression models were used to assess the association between tumor histology and VTE. We identified VTE risk factors with subgroup analyses of patients with pNEN. Results: Among 60,649 eligible patients, 2135 (3.5%) patients developed VTE postoperatively. Of 7572 patients undergoing surgery for pNEN, 270 (3.6%) developed VTE with no difference in postoperative VTE frequency based on histology (3.6% in pNEN vs 3.5% in non-pNEN). On multivariable analysis, pNEN histology compared with pancreatic adenocarcinoma was not associated with increased risk of VTE (adjusted odds ratio [OR], 1.16; 95% CI, 0.97-1.37) or pulmonary embolism (OR, 1.14; 95% CI, 0.88-1.49); however, these patients had higher adjusted risk of deep venous thrombosis (OR, 1.25; 95% CI, 1.02-1.52). In patients with pNEN, variables independently associated with VTE included higher body mass index, preoperative transfusion, longer operative time, total pancreatectomy, and longer hospitalization. Conclusion: While patients with pNEN undergoing pancreatectomy experience postoperative VTE at frequencies comparable with other pancreatic histologies, we observed a higher risk for deep venous thrombosis. We identified risk factors for postoperative VTE in patients with pNEN, which informs decisions on perioperative thromboprophylaxis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.